Evidence map›Paper›PMID 36894557›Full record

ArticleNature communications2023

N-acetylneuraminic acid links immune exhaustion and accelerated memory deficit in diet-induced obese Alzheimer's disease mouse model.

Stefano Suzzi, Tommaso Croese, Adi Ravid, Or Gold, Abbe R Clark, Sedi Medina, Daniel Kitsberg, Miriam Adam, Katherine A Vernon, Eva Kohnert and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Immune dysfunction in Alzheimer disease.Nature reviews. Neuroscience · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 2 countries.

Stefano Suzzi *Weizmann Institute of Science, Department of Brain Sciences, Rehovot, Israel. stefano.suzzi@weizmann.ac.il.ORCID 0000-0002-8135-7794
Tommaso Croese *Weizmann Institute of Science, Department of Brain Sciences, Rehovot, Israel.ORCID 0000-0002-3805-3429
Adi RavidThe Hebrew University of Jerusalem, Edmond & Lily Safra Center for Brain Sciences, Jerusalem, Israel.
Or GoldThe Hebrew University of Jerusalem, Edmond & Lily Safra Center for Brain Sciences, Jerusalem, Israel.
Abbe R ClarkBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Sedi MedinaWeizmann Institute of Science, Department of Brain Sciences, Rehovot, Israel.
Daniel KitsbergThe Hebrew University of Jerusalem, Edmond & Lily Safra Center for Brain Sciences, Jerusalem, Israel.
Miriam AdamThe Hebrew University of Jerusalem, Edmond & Lily Safra Center for Brain Sciences, Jerusalem, Israel.
Katherine A VernonBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Eva KohnertBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Inbar ShapiraThe Hebrew University of Jerusalem, Edmond & Lily Safra Center for Brain Sciences, Jerusalem, Israel.ORCID 0000-0002-8016-1749
Sergey MalitskyWeizmann Institute of Science, Life Sciences Core Facilities, Rehovot, Israel.ORCID 0000-0003-4619-7219
Maxim ItkinWeizmann Institute of Science, Life Sciences Core Facilities, Rehovot, Israel.ORCID 0000-0003-1348-2814
Alexander BrandisWeizmann Institute of Science, Life Sciences Core Facilities, Rehovot, Israel.
Tevie MehlmanWeizmann Institute of Science, Life Sciences Core Facilities, Rehovot, Israel.
Tomer M SalameWeizmann Institute of Science, Life Sciences Core Facilities, Rehovot, Israel.
Sarah P ColaiutaWeizmann Institute of Science, Department of Brain Sciences, Rehovot, Israel.ORCID 0000-0002-9071-9857
Liora CahalonWeizmann Institute of Science, Department of Brain Sciences, Rehovot, Israel.
Michal SlyperBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Anna GrekaBroad Institute of MIT and Harvard, Cambridge, MA, USA. agreka@broadinstitute.org.ORCID 0000-0001-5697-7791
Naomi HabibThe Hebrew University of Jerusalem, Edmond & Lily Safra Center for Brain Sciences, Jerusalem, Israel. naomi.habib@mail.huji.ac.il.ORCID 0000-0002-6049-2487
Michal SchwartzWeizmann Institute of Science, Department of Brain Sciences, Rehovot, Israel. michal.schwartz@weizmann.ac.il.ORCID 0000-0003-4015-7507
Weizmann Institute of Science · ILHebrew University of Jerusalem · ILBroad Institute · US

Funding

Molecular mechanisms of podocyte injury in FSGSR01DK095045 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Anna Greka, Juan Lorenzo Pablo · 2014 to 2026
$5.1M
Role of TRPC5 channel inhibition in the treatment of glomerular diseaseR01DK099465 · NIDDK · BROAD INSTITUTE, INC. · PI Anna Greka · 2014 to 2026
$5.1M
NIDDK NIH HHS R01 DK095045NIDDK NIH HHS R01 DK099465
6 · The paper itself

Abstract

Systemic immunity supports lifelong brain function. Obesity posits a chronic burden on systemic immunity. Independently, obesity was shown as a risk factor for Alzheimer's disease (AD). Here we show that high-fat obesogenic diet accelerated recognition-memory impairment in an AD mouse model (5xFAD). In obese 5xFAD mice, hippocampal cells displayed only minor diet-related transcriptional changes, whereas the splenic immune landscape exhibited aging-like CD4

Indexed as

Alzheimer DiseaseAnimalsDiet, High-FatDisease Models, AnimalHumansMemory DisordersMiceMice, TransgenicN-Acetylneuraminic AcidObesityN-Acetylneuraminic Acid

Identifiers

PMID36894557
PMCPMC9998639
OpenAlexW4323662005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.